Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Centene Corporation

Centene ( ($CNC) ) has provided an update. On May 12, 2026, Centene’s board confirmed a refreshed senior leadership roster aligned with its core bu...

Centene refreshes leadership team and affirms governance direction

In a report released yesterday, Brett Knoblauch from Cantor Fitzgerald reiterated a Hold rating on Coincheck Group, with a price target of $2.50. T...

Cantor Fitzgerald Sticks to Their Hold Rating for Coincheck Group (CNCK)

Coincheck Group ( ($CNCK) ) has provided an update. Coincheck Group N.V., listed in the U.S. and based in Amsterdam, is the holding company of Coin...

Coincheck Group Reports Volatile Trading and Asset Trends in Latest Monthly Metrics

First Citizens BancShares ( ($FCNCA) ) has issued an update. First Citizens BancShares held its 2026 Annual Stockholder’s Meeting on May 4, 2026, w...

First Citizens BancShares Stockholders Back Directors and Pay Plans

Analysts are intrested in these 5 stocks: ( ($CAH) ), ( ($MCK) ), ( ($ZETA) ), ( ($CNC) ) and ( ($ABAT) ). Here is a breakdown of their recent


Cardinal, McKesson, Zeta, Centene, ABAT Trending With Analysts

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Centene (CNC) and Syndax Pharmaceuticals (SNDX). Centene (CNC) TD...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Centene (CNC) and Syndax Pharmaceuticals (SNDX)

In a report released today, Stephen Baxter from Wells Fargo maintained a Hold rating on Centene, with a price target of $56.00. Baxter covers the H...

Wells Fargo Remains a Hold on Centene (CNC)

The SPDR S&P 500 ETF Trust ($SPY) declined 0.02% today, April 29, as investors weighed big earnings reports, rising energy prices from geopolitical...

Why Is the SPY ETF Down Today, 4/29/2026?

Truist Financial analyst David S Macdonald reiterated a Buy rating on Centene today and set a price target of $58.00. S Macdonald covers the Health...

Current Quarter	$0.77	Next Quarter	$0.19
Current Year	$3.45	Next Year	$4.41
QoQ Growth	-75.3%	YoY Growth	+27.8%
3Y EPS CAGR	-100.0%	Target Price	$57.00
Consensus	Buy	Upside	-0.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CNC	$57.21	-3.26%	4.26M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CNC	$57.21	-3.3%	4.26M
3
4
5
6

CNC

CNC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Centene Corporation Data in Excel

Get Centene Corporation Data in Excel